Neurexins are presynaptic adhesion molecules that organize synapses by binding to diverse trans-synaptic ligands, but how neurexins are regulated is incompletely understood. Here we identify FAM19A/TAFA proteins, “orphan" cytokines, as neurexin regulators that interact with all neurexins, except for neurexin-1γ, via an unusual mechanism. Specifically, we show that FAM19A1-A4 bind to the cysteine-loop domain of neurexins by forming intermolecular disulfide bonds during transport through the secretory pathway. FAM19A-binding required both the cysteines of the cysteine-loop domain and an adjacent sequence of neurexins. Genetic deletion of neurexins suppressed FAM19A1 expression, demonstrating that FAM19As physiologically interact with neurexins. In hippocampal cultures, expression of exogenous FAM19A1 decreased neurexin O-glycosylation and suppressed its heparan sulfate modification, suggesting that FAM19As regulate the post-translational modification of neurexins. Given the selective expression of FAM19As in specific subtypes of neurons and their activity-dependent regulation, these results suggest that FAM19As serve as cell type–specific regulators of neurexin modifications.
Skip Nav Destination
Close
Article navigation
7 September 2020
Article|
July 24 2020
Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism
In Special Collection:
Cellular Neurobiology 2020
Anna J. Khalaj,
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Correspondence to Anna J. Khalaj: ajkhalaj@stanford.edu
Search for other works by this author on:
Fredrik H. Sterky,
Fredrik H. Sterky
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Alessandra Sclip,
Alessandra Sclip
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Jochen Schwenk,
Jochen Schwenk
2
Institute of Physiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
Search for other works by this author on:
Axel T. Brunger,
Axel T. Brunger
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Search for other works by this author on:
Bernd Fakler,
Bernd Fakler
2
Institute of Physiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
3
Centres for Biological Signalling Studies (BIOSS) and Integrative Biological Signalling Studies (CIBSS), Freiburg, Germany
4
Center for Basics in NeuroModulation, Freiburg, Germany
Search for other works by this author on:
Thomas C. Südhof
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Thomas C. Südhof: tcs1@stanford.edu
Search for other works by this author on:
Anna J. Khalaj
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Fredrik H. Sterky
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Alessandra Sclip
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Jochen Schwenk
2
Institute of Physiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
Axel T. Brunger
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Bernd Fakler
2
Institute of Physiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
3
Centres for Biological Signalling Studies (BIOSS) and Integrative Biological Signalling Studies (CIBSS), Freiburg, Germany
4
Center for Basics in NeuroModulation, Freiburg, Germany
Thomas C. Südhof
1
Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
Correspondence to Anna J. Khalaj: ajkhalaj@stanford.edu
Thomas C. Südhof: tcs1@stanford.edu
Received:
April 21 2020
Revision Received:
June 01 2020
Accepted:
June 05 2020
Online Issn: 1540-8140
Print Issn: 0021-9525
Funding:
Deutsche Forschungsgemeinschaft
(EXC 2189, 390939984)
National Institutes of Health
(MH052804, R37MH63105)
National Science Foundation
(DGE-114747)
© 2020 Khalaj et al.
2020
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Cell Biol (2020) 219 (9): e202004164.
Article history
Received:
April 21 2020
Revision Received:
June 01 2020
Accepted:
June 05 2020
Citation
Anna J. Khalaj, Fredrik H. Sterky, Alessandra Sclip, Jochen Schwenk, Axel T. Brunger, Bernd Fakler, Thomas C. Südhof; Deorphanizing FAM19A proteins as pan-neurexin ligands with an unusual biosynthetic binding mechanism. J Cell Biol 7 September 2020; 219 (9): e202004164. doi: https://doi.org/10.1083/jcb.202004164
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
1,758
Views
0
Citations
Advertisement
Advertisement